carbonthatcarbonthat
← Every company

Inovio Pharmaceuticals Inc Patents

What Inovio Pharmaceuticals Inc has filed at the patent office — applications as well as grants, because a filing is on the record eighteen months before anyone has to say what it was for.

INO on carbonthat →
Filings on file
25
Granted
2
Still pending
23
Filed under
2 names

25 filings

Newest filing first. A pending application has no patent number yet, and most never get one.

InventionPatent
IMMUNOGENIC COMPOSITIONS FOR RECURRENT RESPIRATORY PAPILLOMATOSISFiled as INOVIO PHARMACEUTICALS, INC.2026-03-13STEPHANIE RAMOSpending
Immunogenic Compositions For Recurrent Respiratory PapillomatosisFiled as Inovio Pharmaceuticals, Inc.2026-02-17Stephanie Ramospending
Immunogenic Compositions For Recurrent Respiratory PapillomatosisFiled as Inovio Pharmaceuticals, Inc.2026-01-27Stephanie Ramospending
TREATMENT OF HEAD AND NECK CANCERFiled as INOVIO PHARMACEUTICALS, INC.2025-12-30JEFFREY SKOLNIKpending
Immunogenic Compositions For Recurrent Respiratory PapillomatosisFiled as Inovio Pharmaceuticals, Inc.2025-12-09Stephanie Ramospending
Vaccines For Recurrent Respiratory Papillomatosis And Methods Of Using The SameA61K 39/12, C07K 14/005, A61P 31/20, A61K2039/5254, A61K2039/53, A61K2039/54, A61K2039/55538, A61K2039/572, A61K2039/575, C07K 14/025, C07K2319/00, C12N2710/16634, C12N2710/20022, C12N2710/20034, C12N2710/20071Filed as Inovio Pharmaceuticals, Inc.2025-10-29Stephanie Ramospending
Cancer Vaccines and Methods of Treatment Using The SameA61K 39/001157, A61K 38/20, A61K 39/39, C07K 14/47, A61P 35/00, A61K 9/0009, A61K 39/0011, A61K2039/53, A61K2039/54, A61K2039/552, A61K2039/55527, A61K2039/55538, A61K2039/572, A61K2039/585, C07K 14/4748, C12N 9/1276, C12Y 207/07049, A61K2300/00Filed as Inovio Pharmaceuticals, Inc.2025-06-25Jian Yanpending
VACCINES HAVING AN ANTIGEN AND INTERLEUKIN-21 AS AN ADJUVANTA61K 39/39, A61P 37/04, A61P 43/00, Y02A 50/30, A61K 39/015, A61K 39/08, A61K 39/12, A61K 39/145, A61K 39/21, A61K 41/0047, A61K 48/00, A61K2039/53, A61K2039/55527, A61N 1/327, C07K 14/54, C12N2740/16134Filed as Inovio Pharmaceuticals, Inc.2025-04-21David B. Weinerpending
CANCER VACCINES TARGETING MUC16 AND USES THEREOFA61K 39/00117, A61K2039/53, A61K2039/54, A61K2039/572, C07K 14/4727, C07K 14/4748Filed as Inovio Pharmaceuticals, Inc.2025-03-25Jian YANpending
Immunogenic Compositions For Recurrent Respiratory PapillomatosisFiled as Inovio Pharmaceuticals, Inc.2025-03-17Stephanie Ramospending
Filovirus Consensus Antigens, Nucleic Acid Constructs and Vaccines Made Therefrom, and Methods of Using SameC07K 14/005, A61P 31/12, A61P 31/14, A61K 9/0009, A61K 38/00, A61K 39/12, A61K 39/39, A61K2039/53, A61K2039/54, A61K2039/545, A61K2039/55527, A61K2039/55538, A61K2039/58, A61K2039/70, C07K 14/54, C07K 14/5434, C07K 14/5443, C07K2319/02, C12N 15/87, C12N2760/14122, C12N2760/14134Filed as Inovio Pharmaceuticals, Inc.2025-03-03David B. Weinerpending
CANCER VACCINES TARGETING BORIS AND USES THEREOFA61K 39/001152, C12N 15/63, A61P 35/00, A61K 39/001184, A61K 39/0011, A61K2039/5154, A61K2039/5156, A61K2039/5158, A61K2039/53, A61K2039/54, A61K2039/55516, A61K2039/572, C07K 14/4702, C07K 14/4748, C12N2830/50Filed as Inovio Pharmaceuticals, Inc.2024-11-01Jian YANpending
INTRADERMAL JET INJECTION ELECTROPORATIONA61B 17/205, A61M 5/30, A61M 5/3007, A61K 9/0021, A61M 5/172, A61M 5/20, A61M 5/24, A61M 5/315, A61M 5/31511, A61M 37/0015, A61M2005/2013, A61M2037/0007, A61M2205/82, A61N 1/0412, A61N 1/327Filed as Inovio Pharmaceuticals, Inc.2024-08-02Jay McCoypending
Foot and Mouth Disease Virus (FMDV) Consensus Proteins, Coding Sequences Therefor and Vaccines Made TherefromC07K 14/005, A61P 37/04, A61P 31/14, A61K 39/12, A61K 39/135, A61K 39/39, A61K2039/523, A61K2039/53, A61K2039/552, A61K2039/55527, A61K2039/55538, A61M 37/00, A61N 1/327, C07K 14/5434, C07K 14/5443, C12N 7/00, C12N 15/87, C12N2770/32122, C12N2770/32134, G01N 33/56983, G01N2333/09, G01N2469/20Filed as Inovio Pharmaceuticals, Inc.2024-07-10David B. Weinerpending
OPTIMIZED NUCLEIC ACID ANTIBODY CONSTRUCTSC07K 16/116, C07K 16/28, A61P 31/14, G16B 30/10, G16B 15/20, C07K 16/11, A61K 39/42, A61K 48/00, A61K2039/505, A61K2039/507, A61K2039/51, A61K2039/53, A61K2039/54, C07K 16/00, C07K 16/10, C07K2317/31, C07K2317/40, C07K2317/522, C07K2317/524, C07K2317/53, C07K2317/565, C07K2317/567, C07K2317/622, C07K2317/64, C07K2317/66, C07K2317/76, C07K2317/92, C12N 15/1031, C12N 15/1079Filed as INOVIO PHARMACEUTICALS, INC.2024-07-08David Weinerpending
CANCER VACCINES TARGETING SURVIVIN AND USES THEREOFA61K 39/00115, A61K 48/00, C07K 14/4702, C07K 16/40, A61P 35/00, A61K2039/80, A61K 39/39, A61K2039/53, A61K2039/55527, A61K2039/575, A61K2039/585, C07K 14/435, C12N 15/52, C12N 15/62, C12N 15/63, C12N 15/86Filed as Inovio Pharmaceuticals, Inc.2024-07-08Jian YAN12679904
Consensus Prostate Antigens, Nucleic Acid Molecule Encoding The Same And Vaccine And Uses Comprising The SameC07K 14/4748, C12N 9/485, C12N 9/6424, Y02A 50/30, A61K 39/001195, A61K 39/001193, A61K 39/001194, A61K2039/884, A61K 31/7088, A61K 38/00, A61K 39/00, A61K 39/0011, A61K2039/53, C12Y 116/01, C12Y 304/17021, C12Y 304/21077Filed as Inovio Pharmaceuticals, Inc.2024-05-10David Weinerpending
DNA ANTIBODY CONSTRUCTS FOR USE AGAINST MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUSC07K 16/1002, C12N 15/63Filed as INOVIO PHARMACEUTICALS, INC.2024-05-07David Weinerpending
KINETIC VACUUM TREATMENT DEVICES, SYSTEMS, AND METHODSFiled as INOVIO PHARMACEUTICALS, INC.2024-04-26PAUL FISHERpending
KINETIC VACUUM TREATMENT DEVICES, SYSTEMS, AND METHODSA61M 5/425, A61M 37/00, A61M 5/3287, A61M 5/46, A61M2037/0007Filed as Inovio Pharmaceuticals, Inc.2024-04-26Paul Fisherpending
CANCER VACCINES TARGETING MESOTHELIN AND USES THEREOFA61K 39/39, A61P 35/00, A61K 39/001168, A61K2039/53, A61K2039/55527, A61K2039/55538Filed as Inovio Pharmaceuticals, Inc.2024-04-16Jian Yanpending
METHODS OF TREATMENT OF HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION (HSIL)Filed as INOVIO PHARMACEUTICALS, INC.2024-03-01KIMBERLY KRAYNYAKpending
METHODS OF TREATMENT OF HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION (HSIL)A61P 31/20, A61K 39/12, A61K 9/0019, A61K 9/08, A61K 47/02, A61K 47/12, A61K2039/53, A61K2039/54, A61K2039/545, A61K2039/572, A61K2039/575, A61K2039/585, A61N 1/327, C12N 7/00, C12N2710/20034, C12Q 1/70Filed as Inovio Pharmaceuticals, Inc.2024-03-01Kimberly A. Kraynyakpending
Hand-Held Electroporation DeviceFiled as Inovio Pharmaceuticals, Inc.2024-01-26Daniel E. WilliamsonD1128906
DNA Monoclonal Antibodies Targeting Checkpoint MoleculesA61P 35/00, A61K 31/7088, C07K 16/2818, C07K 16/2878, C12N 15/85, A61P 37/00, A61P 31/00, Y02A 50/30, A61K 39/001129, A61K 39/0011, A61K 39/395, A61K 48/00, A61K 48/005, A61K2039/505, A61K2039/53, C07K 14/4748, C07K 16/2803, C07K 16/2827, C07K2319/50Filed as Inovio Pharmaceuticals, Inc.2024-01-16David B. Weinerpending

Filings are matched to the company by applicant name, so a subsidiary filing under its own name is only here if that name resolves to this company. The applicant is printed as filed, which makes a wrong match visible. A patent is not a product: most applications are never granted, and most grants are never built.

More on INO

Company overviewEverything on INO in one place, with the price.SEC filingsWhat INO's 8-Ks say happened: results, departures, auditor changes.Who owns itEvery manager reporting a position in INO.Funds holding itWhich funds and ETFs hold INO, and how big a bet.

Related datasets

Corporate LobbyingWhat companies spend lobbying Congress, and on what.Lobbying FirmsThe shops companies hire, and who else they represent.Government ContractsWhat federal agencies pay those same companies.Revolving DoorFormer staff now lobbying, and who they worked for.